Wallonia, Belgium: Life Science Gateway to the European Market 15-10-2019

Wallonia Trade & Investment Agency and BIOWIN (Wallonia's Health Cluster) are cordially inviting you to a Biotech Breakfast Briefing in Boston.

Wallonia, Belgium:  Life Science Gateway to the European Market
Tuesday, October 15th, 2019
8:00 to 10:00 AM
Tufts Launchpad | BioLabs
75 Kneeland Street, Boston (14th floor)

Please join us to learn more about the Wallonia life science cluster with strengths in cell therapy, immunotherapy and vaccines, in immuno-oncology and in the manufacturing of biologics.

Discover why so many pharma and biotech companies choose Wallonia for their European location and the various financial incentives the region has to offer.



  • Greetings

Mr. Frank Geerkens, Consul General of Belgium

  • Doing Business in Belgium, the Example of Wallonia

Mr. Alphi Cartuyvels, Deputy General Manager AWEX - Wallonia Export & Investment Agency

  • Wallonia's Life Sciences Advantage

Dr. Sylvie Ponchaut, PhD, General Manager, BIOWIN, Wallonia Health Cluster

  • Tax Incentives for Foreign Companies Investing in Belgium

Mr. Jean-Charles van Heurck, EY

  • Financial Support and R&D Initiatives

Mr. Marc Foidart, Deputy General Director Meusinvest, Director of Spinventure

  • CAR-T Cell Therapy

Mr. Denis Bedoret, CEO MaSTherCell

  • Agentus Therapeutics Testimonial

Mr. Bruno Lucidi, CEO

  • Q&A

  • Closing Remarks

Dr. Anne Deconinck, Executive Director, The Koch Institute for Integrative Cancer Research at MIT, Honorary Consul of Belgium - New England


Bernard Geenen, Trade & Investment Commissioner AWEX New York
b.geenen@awex-wallonia.com Tel: 212-247-6351